| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.26B | 79.26B | 91.99B | 88.23B | 69.98B | 59.54B |
| Gross Profit | 11.26B | 11.26B | 12.03B | 15.74B | 18.10B | 17.10B |
| EBITDA | 8.82B | 10.00B | 10.71B | 12.39B | 14.89B | 14.44B |
| Net Income | 3.25B | 3.25B | 4.29B | 7.66B | 10.48B | 9.19B |
Balance Sheet | ||||||
| Total Assets | 148.22B | 148.22B | 157.29B | 163.15B | 140.72B | 112.10B |
| Cash, Cash Equivalents and Short-Term Investments | 8.89B | 8.89B | 10.72B | 10.29B | 9.26B | 7.66B |
| Total Debt | 60.42B | 60.42B | 61.39B | 57.70B | 50.70B | 39.92B |
| Total Liabilities | 87.49B | 87.49B | 92.50B | 91.08B | 80.86B | 66.30B |
| Stockholders Equity | 53.86B | 53.86B | 57.90B | 63.58B | 51.94B | 39.60B |
Cash Flow | ||||||
| Free Cash Flow | 1.80B | 1.77B | 2.30B | -673.72M | -1.12B | -2.16B |
| Operating Cash Flow | 6.44B | 6.44B | 8.26B | 8.34B | 7.23B | 4.97B |
| Investing Cash Flow | -1.78B | -1.78B | -10.08B | -15.86B | -8.89B | -9.41B |
| Financing Cash Flow | -3.81B | -3.81B | 2.95B | 8.78B | 2.57B | -883.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$71.93B | 12.01 | 12.60% | 4.30% | -3.19% | -2.68% | |
67 Neutral | HK$43.35B | 14.60 | 8.10% | 4.43% | -4.37% | -41.14% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$132.86B | 23.00 | 9.73% | 4.94% | 0.36% | 2.55% | |
63 Neutral | HK$39.66B | 7.70 | 5.14% | 6.44% | -2.28% | -9.61% | |
56 Neutral | HK$12.67B | 8.67 | 6.35% | 6.38% | 3.86% | 30.34% | |
53 Neutral | HK$16.12B | 21.24 | 6.62% | 1.17% | -6.02% | ― |